-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

661.O1.6 661. Malignant Stem and Progenitor Cells: Novel Mechanisms of Leukemia Stem Cell Function

Malignant Stem and Progenitor Cells Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 4:30 PM-6:00 PM
W304ABCD, Level 3 (Orange County Convention Center)
Moderators:
Liran I. Shlush, MD PhD, University Health Network and Ulrich Steidl, MD PhD, Albert Einstein College of Medicine

Disclosures:
No relevant conflicts of interest to declare.
4:30 PM

Claire Mazumdar1*, Ying Shen2*, Seethu Xavy1*, Feifei Zhao1*, Andreas Reinisch, MD, PhD1*, Rui Li2*, Michael Ryan Corces-Zimmerman, PhD1*, Jason Buenrostro3*, Steven M. Chan, MD, PhD4, Daniel Thomas, MD, PhD5, Julie Koenig1*, Wan-Jen Hong, MD,1, Howard Chang, MD, PhD2* and Ravi Majeti, MD, PhD1

1Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA
2Program in Epithelial Biology and Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford University, Stanford, CA
3Howard Hughes Medical Institute and Department of Genetics, Stanford University, Stanford, CA
4Stanford Cancer Institute, Stanford University, Stanford, CA
5Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, CA

4:45 PM

Shanshan Pei, PhD1*, Mohammad Minhajuddin, PhD1*, Brett M Stevens, PhD1*, Biniam Adane1*, Nabilah Khan, PhD1*, Angelo D'alessandro, PhD2*, Travis Nemkov2*, Kirk C Hansen, PhD2*, Daniel Pollyea, MD, MS1 and Craig T Jordan, PhD1

1Division of Hematology, University of Colorado School of Medicine, Aurora, CO
2Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO

5:00 PM

Jeffrey A. Magee, MD, PhD1, Shaina Porter, Ph.D.2* and Andrew Cluster, MD1*

1Washington University School of Medicine, Saint Louis, MO
2Washington University School of Medicine, St. Louis, MO

5:15 PM

Alex Elder, PhD1*, Helen Blair, PhD1*, Katherine Dormon1*, Simon Bomken, PhD, MBBS1*, Simon J Cockell, PhD2*, Olaf Heidenreich, PhD1* and Josef Vormoor, MD, FRCPCH1

1Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
2Bioinformatics Support Unit, Newcastle University, Newcastle upon Tyne, United Kingdom

5:30 PM

Haobin Ye1,2*, Biniam Adane1*, Nabilah Khan, PhD1*, John M. Ashton, PhD3*, Marlene Balys3*, Brett M Stevens, PhD1*, Mohammad Minhajuddin4* and Craig T Jordan, PhD1

1Division of Hematology, University of Colorado School of Medicine, Aurora, CO
2Department of Pathology, University of Rochester, Rochester, NY
3James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
4University of Colorado School of Medicine, Aurora, CO

5:45 PM

Christopher Booth1*, Nikolas Barkas1*, Wen Hao Neo1*, Elizabeth Soilleux2*, Hanane Boukarabila1*, Alice Giustacchini1*, Thomas Milne1*, Neil Ashley1*, Joana Carrelha1*, Lauren Jamieson1*, Deborah Atkinson1*, Tiphaine Bouriez-Jones1*, Sten Eirik Jacobsen, MD PhD1* and Adam Mead1,3*

1MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
2Department of Cellular Pathology, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom
3NIHR Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom

*signifies non-member of ASH